# Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia

> **NCT00990405** · PHASE4 · UNKNOWN · sponsor: **Korean College of Helicobacter and Upper Gastrointestinal Research** · enrollment: 400 (estimated)

## Conditions studied

- Functional Dyspepsia
- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Lansoprzole+Amoxicillin+Clarithromycin

## Key facts

- **NCT ID:** NCT00990405
- **Lead sponsor:** Korean College of Helicobacter and Upper Gastrointestinal Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-10
- **Primary completion:** 2010-09
- **Final completion:** 2010-12
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2009-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00990405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00990405, "Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00990405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*